Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
Authors
Keywords
Breast cancer, Cancer treatment, Breast tumors, BT474 cells, Lymph nodes, Invasive tumors, Microarrays, Prognosis
Journal
PLoS One
Volume 9, Issue 6, Pages e100759
Publisher
Public Library of Science (PLoS)
Online
2014-06-27
DOI
10.1371/journal.pone.0100759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings
- (2013) T. M. A. Abdel-Fatah et al. ANNALS OF ONCOLOGY
- The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
- (2013) Z M A Mohammed et al. BRITISH JOURNAL OF CANCER
- The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion
- (2013) Mamadou Keita et al. CELL CYCLE
- Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer
- (2013) Zahra M.A. Mohammed et al. HUMAN PATHOLOGY
- Novel prognostic markers for patients with triple-negative breast cancer
- (2013) Ling Zhou et al. HUMAN PATHOLOGY
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
- (2012) Z MA Mohammed et al. BRITISH JOURNAL OF CANCER
- Runx1: no longer just for leukemia
- (2012) Ichiro Taniuchi et al. EMBO JOURNAL
- Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer
- (2012) Cornelia Johanna Franziska Scheitz et al. EMBO JOURNAL
- Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis
- (2012) Zahra M A Mohammed et al. HISTOPATHOLOGY
- Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer
- (2012) Zahra M A Mohammed et al. HISTOPATHOLOGY
- RUNX family: Regulation and diversification of roles through interacting proteins
- (2012) Linda Shyue Huey Chuang et al. INTERNATIONAL JOURNAL OF CANCER
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- (2012) Cornelia Johanna Franziska Scheitz et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Runx1 Deficiency in CD4+ T Cells Causes Fatal Autoimmune Inflammatory Lung Disease Due to Spontaneous Hyperactivation of Cells
- (2012) W. F. Wong et al. JOURNAL OF IMMUNOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The RUNX family in breast cancer: relationships with estrogen signaling
- (2012) N-O Chimge et al. ONCOGENE
- Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF interaction
- (2012) L. Cunningham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triple-negative breast cancer: are we making headway at least?
- (2012) Monica Arnedos et al. Therapeutic Advances in Medical Oncology
- RUNX1 and its understudied role in breast cancer
- (2011) Kevin A. Janes CELL CYCLE
- RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
- (2011) Kentson Lam Frontiers in Bioscience-Landmark
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
- (2011) Thomas Karn et al. PLoS One
- Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression
- (2011) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Runx1 Directly Promotes Proliferation of Hair Follicle Stem Cells and Epithelial Tumor Formation in Mouse Skin
- (2010) C. S. L. Hoi et al. MOLECULAR AND CELLULAR BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
- (2010) Mitsutaka Kadota et al. PLoS One
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
- (2009) Hsiang-Yuan Yeh et al. BMC Medical Genomics
- Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
- (2008) Clare A. Thibodeaux et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started